The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NovoCure Limited(NASDAQ:NVCR) 
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients wit...
Website: https://www.novocure.com/
Founded: 2000
Full Time Employees: 782
CEO: Asaf Danziger
Sector: Healthcare
Industry: Medical Instruments & Supplies
NovoCure Number of Twitter Followers
NovoCure Days Payable Outstanding ttm (DPO)
NovoCure Days Receivable Outstanding ttm (DSO)
NovoCure Days Inventory Outstanding ttm (DIO)
NovoCure Op Cashflow Per Share ttm
NovoCure Free Cashflow Per Share ttm
NovoCure Cash Per Share ttm
NovoCure P/S ratio ttm
NovoCure (GAAP) P/E ratio ttm
NovoCure P/B ratio ttm
No extra charts and metrics for this ticker.